Delivery Order SPE2DB20D9135-SPE2DB22FD3CE

Award Date 7/15/22
Potential Completion Date 8/5/22
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,714.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the specialty pharmaceutical product Kcentra. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,602.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the blood coagulant Kcentra, with a completion date of October 9, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a $5,107.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is to provide Kcentra 500unit 1s, a specialized pharmaceutical product, with a period of performance through December 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $71,427.84 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the medication KCENTRA, with a completion date of August 14, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $9,977.28 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 500-unit vials of Kcentra, a blood coagulant medication, with a performance period ending on April 12, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, valued at up to $4,999,999, which enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,991.04 firm fixed-price delivery order is for the supply of 1,000 unit vials of the medication Kcentra. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a firm fixed-price delivery order valued at $8,727.84. The award was made by the Defense Logistics Agency (DLA), a defense agency, to fulfill the recurring pharmaceutical supply needs of military health facilities worldwide. The contract covers the delivery of 1,000-unit vials of the drug Kcentra to support the medical requirements of the Department of Defense (DoD)....
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,116.07 firm fixed-price delivery order is for the provision of 1,000 unit vials of the pharmaceutical drug Kcentra. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, provides for the delivery of KCENTRA 1,000 unit vials to the Defense Logistics Agency (DLA). The $17,297.60 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for the delivery of 1,000 unit vials of the biologic medication KCENTRA. The contract has a firm fixed-price, delivery order type, with a ceiling value of $58,453.12 and a period of performance through May 13, 2024. The contract is not associated with a set-aside...
  • SPE2DB20D9135
    Indefinite Delivery Contract
  • SPE2DB20D9135-SPE2DB22FD3CE
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,880.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 1,000 unit vials of the drug Kcentra. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group has established itself as a key supplier in the federal pharmaceutical supply chain, providing critical medications and medical supplies to the Department of Defense and Department of Veterans Affairs.

Generated 1/9/25, 9:14 AM